Eddid Financial: 160 Health (2656.HK) Launched Its IPO

160 Health (2656.HK), a pharmaceutical and healthcare product wholesaler and digital healthcare integrated service provider in China, launched its IPO today.

160 Health (the “Company”) intends to issue 33,645,500 shares, with an offer price HK$ 11.89-14.86 per share. Each lot will consist of 250 shares, requiring an entry fee of approximately HK$3,752.47. The maximum amount raised through this IPO is estimated to be around HK$500 million. The offer period will run from Sep 9 to Sep12, and the Company is expected to be listed on Sep 17.

The Company provides a wide selection of pharmaceutical and healthcare products, as well as comprehensive digital healthcare and wellness solutions. By offering a broad assortment of high-quality products and delivering digital healthcare and wellness services through its online platform, Healthcare 160 Platform, the Company empowers all Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, across the healthcare value chain, thereby driving the digital transformation of China’s healthcare and wellness industry. Originating in Shenzhen, the Company has firmly established a leading position in the city’s integrated digital healthcare service sector. Building on this success, it has developed a digital healthcare and wellness service platform that enables reliable online healthcare access anytime, anywhere. the Company had extended its service coverage to over 260 cities across China.

Eddid Financial is one of the Joint Bookrunners and Joint Lead Managers for the launch of 160 Health’s IPO.

The IPO subscription period commences today. Interested investors should stay tuned for updates.

Prospectus: https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0909/2025090900019.pdf

Investment involves risks, be cautious of trading.

Information Details

Eddid Financial: 160 Health (2656.HK) Launched Its IPO